EPO mRNA-LNP

Cat. No.: TDLD-0825-LD14

EPO mRNA-LNP

EPO mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding Erythropoietin (EPO), serving as an excellent tool for studying hematopoiesis, evaluating LNP-mediated protein production, and investigating potential therapeutic applications related to red blood cell production. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. We offer flexibility in lipid composition, including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and targeted lipids for specific tissues (lung, liver, spleen, muscle), allowing for tailored delivery strategies. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of EPO mRNA-LNP include assessing the efficacy of LNP formulations for protein delivery, studying the kinetics of EPO expression and its physiological effects, and serving as a model for protein-based therapies. Please note that this product is intended for research purposes only.